ROS-1 Fusions in Non-Small-Cell Lung Cancer: Evidence to Date

S. Gendarme(Inserm), Florian Guisier(Inserm)

Current Oncology

January 28, 2022

10.3390/curroncol29020057

Cited by 118

Related Papers

ROS1-rearranged NSCLC With Secondary Resistance Mutation: Case Report and Current Perspectives

|Clinical Lung Cancer|2019|18

In- and ex-vivo molecular imaging of apoptosis to assess sensitivity of non-small cell lung cancer to EGFR inhibitors using probe-based confocal laser endomicroscopy

|PLoS ONE|2017|9

Correlation of programmed death-ligand 1 expression in tumour cells between diagnostic small biopsies performed by radial EBUS and surgical specimens of peripheral lung cancer

|BMJ Open Respiratory Research|2024|3